We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 08, 2019

Copayment Reduction Intervention in the ARTEMIS Trial

JAMA Cardiology


Additional Info

JAMA Cardiology
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial
JAMA Cardiol 2019 Nov 13;[EPub Ahead of Print], AC Fanaroff, ED Peterson, LA Kaltenbach, CP Cannon, NK Choudhry, TD Henry, KJ Anstrom, DJ Cohen, E Fonseca, ND Khan, GC Fonarow, TY Wang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading